Filters: Keyword is Dogs [Clear All Filters]
H
Helfand SC, Modiano JF, Nowell PC.
1992. Immunophysiological studies of interleukin-2 and canine lymphocytes.. Veterinary immunology and immunopathology. 33(1-2):1-16. Abstract
Helfand SC, Soergel SA, Donner RL, Gan J, Hank JA, Lindstrom MJ, Sondel PM.
1994. Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy model.. Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy. 16(3):188-97. Abstract
Helfand SC, Jain NC, Paul M.
1984. Vincristine-loaded platelet therapy for idiopathic thrombocytopenia in a dog.. Journal of the American Veterinary Medical Association. 185(2):224-6.
Helfand SC, Hank JA, Gan J, Sondel PM.
1996. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.. Cellular immunology. 167(1):99-107. Abstract
Helfand SC.
1988. Neoplasia and immune-mediated thrombocytopenia.. The Veterinary clinics of North America. Small animal practice. 18(1):267-70.
Helfand SC, Dickerson EB, Munson KL, Padilla ML.
1999. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.. Cancer research. 59(13):3119-27. Abstract
Helfand SC, Soergel SA, MacWilliams PS, Hank JA, Sondel PM.
1994. Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs.. Cancer immunology, immunotherapy : CII. 39(2):84-92. Abstract
Hellyer PW, Bai L, Supon J, Quail C, Wagner AE, Mama KR, Magnusson KR.
2003. Comparison of opioid and alpha-2 adrenergic receptor binding in horse and dog brain using radioligand autoradiography.. Veterinary anaesthesia and analgesia. 30(3):172-82. Abstract







